47.28
-0.87(-1.81%)
Currency In USD
| Previous Close | 48.15 |
| Open | 48.1 |
| Day High | 48.1 |
| Day Low | 46.58 |
| 52-Week High | 50.79 |
| 52-Week Low | 23.23 |
| Volume | 232,923 |
| Average Volume | 516,306 |
| Market Cap | 1.49B |
| PE | 29.01 |
| EPS | 1.63 |
| Moving Average 50 Days | 45.78 |
| Moving Average 200 Days | 35.44 |
| Change | -0.87 |
If you invested $1000 in Collegium Pharmaceutical, Inc. (COLL) 10 years ago, it would be worth $2,907.75 as of January 14, 2026 at a share price of $47.28. Whereas If you bought $1000 worth of Collegium Pharmaceutical, Inc. (COLL) shares 5 years ago, it would be worth $2,121.13 as of January 14, 2026 at a share price of $47.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Collegium Provides 2026 Financial Guidance and Business Update
GlobeNewswire Inc.
Jan 08, 2026 1:00 PM GMT
– Product Revenues, Net Expected in the Range of $805 Million to $825 Million – – Jornay PM® Net Revenue Expected in the Range of $190 Million to $200 Million – – Adjusted EBITDA* Expected in the Range of $455 Million to $475 Million – STOUGHTON, Mas
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
GlobeNewswire Inc.
Dec 30, 2025 1:00 PM GMT
Five-Year Financing with Favorable Terms that Significantly Reduce Interest RateSTOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its inaugural syndicated credit facili
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
– Long-time advocate, Paris Hilton, shares her personal ADHD journey from childhood to adulthood to encourage others to speak to their healthcare provider about appropriate treatment options – STOUGHTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) --